https://adisinsight.springer.com/drugs/800087388?error=cookies_not_supported&code=bac1643e-d54f-4026-8827-ad3703086f15
REGN 20423 - AdisInsight
REGN 20423 is being by Regeneron Pharmaceuticals for the treatment of atopic dermatitis. Preclinical development is underway in the US.
regnadisinsight
https://nvd.nist.gov/vuln/detail/CVE-2021-20423
NVD - CVE-2021-20423
nvdcve